---
title: Buy Apresoline (Hydralazine) 25mg Pills Online
description: Apresoline (Hydralazine) 25mg pills is a trusted solution for managing high blood pressure. Order from our secure pharmacy for reliable global delivery.
type: product
language: en 
url: https://medsforsale.net/buy-apresoline-online-en
availability: in_stock
price_min: 38.99
price_max: 112.99
currency: USD
offers:
  - name: 25mg x 30 pills
    price: 38.99
  - name: 25mg x 60 pills
    price: 59.99
  - name: 25mg x 90 pills
    price: 82.99
  - name: 25mg x 120 pills
    price: 89.99
  - name: 25mg x 180 pills
    price: 112.99
---

# Buy Apresoline (Hydralazine) 25mg Pills Online

Apresoline, formulated with Hydralazine Hydrochloride, is a vasodilator originally developed by Novartis to manage hypertension. By relaxing the muscles in your blood vessels, it helps blood flow more easily, reducing the workload on the heart and preventing future cardiovascular complications. It is designed for adults looking for a proven approach to blood pressure management. Our pharmacy ensures a consistent supply of Apresoline, currently available in 25mg pills for your daily health regimen.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **25mg** | 30 pills | **$38.99** | $1.30 | In Stock |
| **25mg** | 60 pills | **$59.99** | $1.00 | In Stock |
| **25mg** | 90 pills | **$82.99** | $0.92 | In Stock |
| **25mg** | 120 pills | **$89.99** | $0.75 | In Stock |
| **25mg** | 180 pills | **$112.99** | $0.63 | In Stock |


[Buy Now](https://medsforsale.net/buy-apresoline-online-en)

## Introduction 
Apresoline contains the vasodilator hydralazine hydrochloride, a medication used primarily to lower high blood pressure and to relieve heart failure caused by reduced cardiac output. The drug is supplied as oral tablets, most commonly in a 25 mg strength. It belongs to the class of direct-acting arteriolar smooth-muscle relaxants. In addition to its approved uses, hydralazine has been investigated for certain off-label applications, such as in the management of severe hypertension in pregnancy and as part of combination therapy for resistant hypertension. 

## What is Apresoline? 
Apresoline is a commercially available formulation of hydralazine hydrochloride. Hydralazine was first synthesized in the 1950s and received FDA approval for hypertension treatment in 1955. The medication is marketed under brand names such as Apresoline and Hydergic, while the same active ingredient is also sold as a generic product. [our online pharmacy](https://medsforsale.net/buy-apresoline-online-en) provides this generic alternative, offering a cost-effective option for patients who require long-term blood-pressure control. 

## How Apresoline Works 
Hydralazine acts directly on arteriolar smooth muscle cells. It interferes with intracellular calcium metabolism, leading to relaxation of the vascular smooth muscle and resulting in vasodilation of the arterial circulation. The reduction in peripheral resistance decreases afterload, which in turn lowers systolic blood pressure. Because the drug does not affect venous tone, preload remains relatively unchanged. Onset of action typically occurs within 10-30 minutes after oral administration, with peak effect at 1-2 hours and a duration of 4-6 hours. Hydralazine is metabolized in the liver via acetylation; acetylation rates vary among individuals and can influence both efficacy and adverse-event profiles. 

## Conditions Treated with Apresoline 

- **Essential (primary) hypertension** - By lowering systemic vascular resistance, hydralazine helps achieve target blood-pressure goals when used alone or in combination with other antihypertensives. 
- **Congestive heart failure (NYHA class III-IV)** - The reduction in afterload eases the workload of the left ventricle, improving cardiac output and symptoms such as dyspnea and fatigue. 

These indications are supported by FDA-approved labeling and extensive clinical trial data, including large-scale randomized studies that demonstrated a statistically significant reduction in systolic pressure and improvement in functional class for heart-failure patients. 

## Off-Label and Investigational Uses of Apresoline 

- **Severe hypertension in pregnancy (preeclampsia/eclampsia)** - Small-scale studies and obstetric guidelines have reported that hydralazine can be used intravenously to rapidly lower blood pressure in pregnant women when other agents are contraindicated. This use is not FDA-approved for oral tablets and must be supervised by an obstetric specialist. 
- **Resistant hypertension** - In patients whose blood pressure remains uncontrolled despite three or more antihypertensive agents, adding low-dose hydralazine to a regimen that includes a diuretic and a renin-angiotensin system blocker has shown modest additional blood-pressure reduction in observational cohorts. 
- **Pulmonary arterial hypertension (PAH) adjunct therapy** - Early phase II trials explored hydralazine as a vasodilator adjunct to phosphodiesterase-5 inhibitors, noting improvements in exercise capacity. Evidence remains preliminary and the combination is not an approved indication. 

All off-label applications should only be undertaken under direct supervision of a qualified healthcare provider, as safety and efficacy have not been formally evaluated by regulatory agencies for these purposes. 

## Is Apresoline the Right Medication for You? 
Apresoline is most appropriate for adults with moderate-to-severe essential hypertension or for those with symptomatic congestive heart failure where afterload reduction is desired. It is especially useful when rapid blood-pressure control is needed, or when a patient cannot tolerate calcium-channel blockers or ACE inhibitors. 

**Contraindications** include: 

- Known hypersensitivity to hydralazine or any excipients in the tablet. 
- Severe coronary artery disease with unstable angina, because rapid vasodilation may provoke myocardial ischemia. 
- Systemic lupus erythematosus (SLE) with active disease, as hydralazine can exacerbate drug-induced lupus-like syndrome. 

Patients with impaired hepatic function, particularly those who are slow acetylators, may require lower doses to avoid accumulation and toxicity. 

## Risks, Side Effects, and Interactions 

### Common 
- Headache 
- Flushing 
- Tachycardia (reflex) 
- Nausea 
- Upper-body weakness 

### Rare 
- Drug-induced lupus-like syndrome (arthralgia, rash, serositis) 
- Hyperuricemia leading to gout attacks 
- Severe constipation 

### Serious 
- Myocardial ischemia or infarction (especially in patients with coronary artery disease) 
- Severe hypotension with syncope 
- Anaphylaxis or severe allergic reaction 

**Drug-Drug Interactions** 

- **Beta-blockers** - May blunt reflex tachycardia, allowing higher hydralazine doses but also increasing the risk of bradycardia. 
- **Centrally acting antihypertensives (e.g., clonidine)** - Sudden withdrawal while on hydralazine can precipitate rebound hypertension. 
- **Allopurinol** - Concomitant use may increase the risk of a lupus-like syndrome. 
- **MAO inhibitors** - Concurrent therapy can enhance hypotensive effects. 

**Drug-Food Interactions** 

- Alcohol can intensify vasodilatory effects, leading to marked hypotension. 
- High-salt diets counteract blood-pressure-lowering benefits; patients should follow sodium-restriction recommendations. 

Patients should inform their pharmacist of all prescription, over-the-counter, and herbal products they are taking to avoid unexpected interactions. 

## Use: Dosing, Missed Dose, Overdose 

**Standard dosing** for hypertension typically starts at 25 mg orally two to four times daily. Dose titration is guided by blood-pressure response, with a usual maximum of 300 mg per day divided into several doses. For heart-failure, clinicians often begin with 25 mg three times daily and adjust based on tolerance and clinical status. 

**Missed dose** - If a dose is forgotten within 2 hours of the scheduled time, take it promptly. If it is later than 2 hours, skip the missed dose and resume the regular schedule to avoid excessive vasodilation. 

**Overdose** - Symptoms may include profound hypotension, tachycardia, dizziness, and fainting. Seek emergency medical attention immediately. Supportive care involves intravenous fluids, positional measures, and, if necessary, vasopressor agents under hospital supervision. 

**Practical precautions** - Take tablets with food to reduce gastrointestinal irritation, avoid alcohol, and refrain from operating heavy machinery or driving until the individual’s response to the medication is known. 

## FAQ 

- **What should I do if I travel abroad with Apresoline?** 
 Keep the medication in its original container with the pharmacy label intact. Pack tablets in a carry-on bag to maintain temperature control and present the label at customs if requested. 

- **Can I crush or split Apresoline tablets?** 
 Hydralazine tablets are formulated for oral swallowing; crushing may alter the release profile and increase side-effects. Splitting is acceptable only if a score line is present, and only under pharmacist guidance. 

- **Is there a difference between immediate-release and extended-release hydralazine?** 
 Immediate-release tablets (the 25 mg form) have a rapid onset and require multiple daily doses. Extended-release formulations, where available, provide steadier plasma levels and may reduce dosing frequency, but they are not interchangeable without a prescriber’s instruction. 

- **How does kidney function affect hydralazine dosing?** 
 Hydralazine is primarily metabolized by the liver; renal impairment does not markedly alter clearance. However, patients with severe renal disease should be monitored for fluid balance and electrolyte disturbances, especially when combined with diuretics. 

- **Will hydralazine interfere with drug testing for employment?** 
 Hydralazine is not a substance screened for typical workplace drug panels. Routine employment testing will not detect therapeutic hydralazine use. 

- **Are there specific storage requirements for Apresoline tablets?** 
 Store at controlled room temperature (20-25 °C/68-77 °F). Protect from excessive heat, moisture, and direct sunlight. Do not refrigerate unless advised by the pharmacist. 

- **Can pregnant or breastfeeding women use Apresoline?** 
 Oral hydralazine is classified as Pregnancy Category C; it may be prescribed when the potential benefit justifies the potential risk. It is excreted in breast milk in small amounts; caution is advised, and a healthcare provider should evaluate the risk-benefit ratio. 

- **What is the rationale for combining hydralazine with nitrates in heart failure?** 
 Nitrates provide venous dilation, reducing preload, while hydralazine reduces afterload. The complementary actions improve cardiac efficiency and have been shown in clinical trials (e.g., the A-HeFT study) to reduce mortality in African-American patients with heart failure. 

- **How does genetic acetylation status influence side-effects?** 
 Individuals who are “slow acetylators” metabolize hydralazine more slowly, leading to higher plasma concentrations and an increased likelihood of lupus-like syndrome and other adverse reactions. Genetic testing is not routinely required but may be considered in refractory cases. 

- **Is it safe to consume caffeine while taking Apresoline?** 
 Caffeine can cause mild vasoconstriction, potentially attenuating the blood-pressure-lowering effect of hydralazine. Moderate consumption is unlikely to be clinically significant, but patients should monitor blood pressure and discuss large caffeine intake with their pharmacist. 

- **Can hydralazine be used in patients with peripheral arterial disease?** 
 Because hydralazine predominantly dilates arterioles, it may improve peripheral blood flow; however, rapid vasodilation can precipitate reflex tachycardia, which may exacerbate ischemic leg pain. Use with caution and under professional supervision. 

## Glossary 

**Vasodilator** 
: A drug that widens blood vessels, decreasing vascular resistance and lowering blood pressure. 

**Afterload** 
: The pressure against which the heart must pump blood; reduction improves cardiac output in heart failure. 

**Lupus-like syndrome** 
: An adverse immune reaction resembling systemic lupus erythematosus, characterized by joint pain, rash, and positive anti-histone antibodies, occasionally triggered by hydralazine. 

**Acetylation** 
: A metabolic process in the liver that modifies drugs; genetic variations affect the speed of hydralazine clearance. 

## Buying Apresoline from [our online pharmacy](https://medsforsale.net/buy-apresoline-online-en) 
Apresoline can be obtained through [our online pharmacy](https://medsforsale.net/buy-apresoline-online-en), a trusted broker that sources the medication from licensed, overseas suppliers. We offer the generic hydralazine hydrochloride at a price close to the manufacturer’s cost, making long-term therapy more affordable. All products are verified for authenticity and quality before shipment, and we employ a discreet packaging method to protect your privacy. Delivery options include a standard airmail service that typically arrives within three weeks, and an express service that delivers in 7 days for urgent needs. By operating as a pharmacy broker, we can provide access to medications that may be unavailable or expensive through local channels, while maintaining strict adherence to safety and regulatory standards. 

## Disclaimer 
The information presented about Apresoline is intended for general educational purposes only and does not replace professional medical advice. All therapeutic decisions, including any consideration of off-label use, must be made under the supervision of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-apresoline-online-en) makes Apresoline available for individuals who encounter limited access through conventional pharmacies or insurance programs, or who are seeking cost-effective generic alternatives. Consult a qualified provider before initiating, modifying, or discontinuing any medication.